Short answer
As of October 2026, Google gates telehealth ads at the advertiser (LegitScript and Google certification), Meta at the content (plus LegitScript and authorization for prescription drug ads), and TikTok at the product (US prescription ads need proof of FDA approval). MedScale Health, a paid ads agency for US telehealth brands and clinics, plans the channel mix around those three gates and runs TikTok only for non-prescription offers. Compounded drugs cannot meet TikTok's rule, and its prescription ads must target people 18 or older.
What does each ad platform restrict in telehealth advertising?
Treating platform policy as a single body of rules is the most common planning error in this category. MedScale works with telehealth brands and clinics, and the more useful model is that each platform is solving a different problem, which is why the same campaign can pass on one and fail on another for reasons that appear unrelated. MedScale's free audit applies that model to a live account, setting out which of Meta, Google, Microsoft and TikTok the category can run today, which need certification first and which are closed.
- Google gates primarily at the advertiser level, through certification.
- Meta gates primarily at the content level, through rules on what creative may claim and depict, and adds LegitScript and authorization for prescription drug ads.
- TikTok gates primarily at the product level: in the United States a prescription medicine ad needs proof of FDA approval, which compounded and unapproved products cannot supply.
What does Google require from a telehealth advertiser?
Google's structure means an uncertified telehealth advertiser fails uniformly, across every campaign, regardless of creative quality. Google allows US telemedicine providers accredited by LegitScript's Healthcare Merchant Certification Program and certified with Google. Once certification is in place, a substantial amount of direct healthcare messaging becomes available, subject to the healthcare and medicines policies and to landing page review.
Google's drug-name rule moved recently. Since October 29, 2025, Google's restricted drug terms policy for the United States lets advertisers name prescription drugs in ads and landing pages without certification, but requires certification to keyword-target those terms, and still requires online pharmacies, telemedicine providers and pharmaceutical manufacturers to be certified. An in-person clinic gains drug names in ad copy; a telehealth prescriber still certifies first.
Google therefore rewards front-loading compliance work. The effort is concentrated in getting certified, after which the day to day creative constraint is lighter than on Meta. MedScale confirms Google certification before it builds a telehealth search account.
What does Meta restrict in telehealth ads?
Meta permits a broad range of healthcare advertisers without an equivalent certification gate, and applies pressure at the creative layer instead. The personal attributes rules and the Health and Wellness claim rules are where telehealth campaigns fail. Meta loosened the imagery side on July 22, 2026: adults-only weight-loss ads may now show before-and-after comparisons, and cosmetic before-and-after now covers Botox and filler results, but statements of inferiority, pinched-fat close-ups and timed outcome promises without a qualifier still fail. The certification gate appears only when an ad promotes a prescription drug, which needs active LegitScript certification and Meta's authorization.
Meta's content gate produces the opposite workload profile from Google. Getting started is easier, and staying compliant is a continuous discipline rather than a one time clearance, because every new creative concept is a new opportunity to violate a content rule. MedScale pre-checks every new Meta concept against the personal attributes and Health and Wellness rules before it spends.
Menopause care runs on Meta without authorization when the ad focuses on health and medical efficacy and targets people 18 or older; naming a prescription hormone turns it into a prescription drug ad.
Can telehealth brands run prescription drug ads on TikTok?
TikTok's Healthcare and Pharmaceuticals policy, last updated September 2026, says prescription medicine ads in the United States may be allowed if the advertiser provides proof of approval and certification from the relevant regulator, such as the FDA, and restricts the ads to people 18 or older. Pharmacies need NABP or LegitScript certification. Most other markets list prescription medicine as not allowed.
The requirement is the product's approval, not only the advertiser's paperwork. A compounded GLP-1 or a peptide is not FDA-approved, so it cannot meet the rule however well the brand is certified. For those offers TikTok stays an awareness or non-prescription channel: the clinic, the consult and provider-led education. MedScale runs TikTok for non-prescription offers and measures it on that job.
Does ad approval on one platform mean approval on another?
No. The most expensive assumption in telehealth media planning is that clearance on one platform predicts clearance on another. Because the three platforms gate at different layers, a concept that passes Google because the advertiser is certified can fail on Meta because of a single line of second-person copy, and can be unavailable on TikTok because of the product itself.
MedScale plans creative against the strictest applicable constraint for each channel rather than producing one concept and adapting it afterwards, because adaptation after the fact tends to preserve the structure that caused the original problem.
Telehealth ad policies change several times a year. Each dated change, with the policy page it came from, is logged at /policy-tracker/changelog.
Common questions
- 01Which platform is easiest for a telehealth brand to start on?
- Meta, usually, because there is no equivalent certification gate, but it demands continuous creative discipline afterwards. Google takes longer to start because of certification and is then somewhat more stable, so the right answer depends on whether the constraint is time or ongoing capacity.
- 02If my ad was approved on Google, will it pass on Meta?
- No, and assuming so is a common source of disapprovals. The platforms restrict different layers, so a Google approval says nothing about whether the creative satisfies Meta's content rules, particularly the personal attributes and imagery restrictions.
- 03Can telehealth brands advertise on TikTok at all?
- Yes, within limits. In the United States TikTok says prescription medicine ads may be allowed with proof of FDA approval and certification and 18+ targeting. Compounded and unapproved products cannot meet that, so for compounded GLP-1 and peptides TikTok stays an awareness or non-prescription channel.
- 04Do these policies differ by country?
- Yes, substantially. Certification requirements, permitted claims and restricted categories are all set regionally, so a campaign cleared for the United States may be prohibited elsewhere. Each target market needs to be confirmed on its own terms rather than inferred from the primary market.
Sources
- 01TikTok Ads policy: Healthcare and Pharmaceuticals (last updated September 2026)checked November 3, 2026
- 02Google Ads policy: Healthcare and medicineschecked October 5, 2026
- 03Google Ads policy: Prescription drug serviceschecked October 5, 2026
- 04Google Ads policy: Restricted drug termschecked October 5, 2026
- 05Meta Advertising Standards: Health and Wellness (updated Jul 22, 2026)checked October 5, 2026
- 06Meta Advertising Standards: Drugs and Pharmaceuticalschecked October 5, 2026
Related answers
How Do You Advertise a Telehealth Brand on Meta Without Losing the Ad Account?
As of October 2026, keeping a telehealth ad account healthy on Meta comes down to three habits: never write copy that implies knowledge of the viewer's health, never send traffic to a page that contradicts the ad, and track disapproval rate as a metric. MedScale Health, a paid ads agency for US telehealth brands and clinics, finds that accounts are almost never lost to a single bad ad but to an accumulating pattern of disapprovals nobody was tracking.
Reviewed October 24, 2026
Why Are Your Google Ads Disapproved for Telehealth, and How Do You Fix It?
As of October 2026, Google disapproves telehealth ads for three recurring reasons: the advertiser is not certified to promote telemedicine or prescription medication, the landing page makes claims the policy treats as unsupported, or the campaign promotes a substance Google restricts outright. MedScale Health, a paid ads agency for US telehealth brands and clinics, checks certification status first, because an uncertified account keeps failing review however carefully the creative is written.
Reviewed October 24, 2026
Who Needs LegitScript Certification to Advertise Telemedicine?
As of November 2026, US telemedicine providers need LegitScript certification before Google or Meta will run their prescription-drug advertising, and online pharmacies need it for Meta and LegitScript or NABP for Google. MedScale Health, a paid ads agency for US telehealth brands and clinics, treats certification as a launch dependency, because campaigns planned around an uncertified account will not deliver. Google names LegitScript as the accreditation for US telemedicine providers, and Meta requires active LegitScript certification plus its own authorization to promote a prescription drug.
Reviewed November 9, 2026
Does Async or Synchronous Care Change What You Can Advertise?
As of October 2026, whether a telehealth brand's care is asynchronous or synchronous changes its advertising in two ways: how platforms and LegitScript categorize the business, and where patient health information enters the funnel. MedScale Health, a paid ads agency for US telehealth brands and clinics, treats the care model as an input to the media plan: async concentrates the risk in the intake flow, and synchronous moves it into scheduling.
Reviewed October 24, 2026
Last reviewed October 24, 2026. Platform policies change often; we re-verify every answer quarterly.